ArticleFrontiers in pharmacology2025

Case Report: A novel MET exon 14 skipping mutation after EGFR-TKI resistance in advanced lung adenocarcinoma and sustained clinical response to savolitinib.

Yinyin Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.